BioSpace News Archive

Dr. Reddy’s Laboratories Ltd. announced its consolidated financial results for the fourth quarter and full year ended March 31, 2023.

Stryker announced that its Board of Directors has declared a quarterly dividend of $0.75 per share payable July 31, 2023 to shareholders of record at the close of business on June 30, 2023, representing an increase of 7.9% versus the prior year and unchanged from the previous quarter.

[10-May-2023] DURHAM, N.C. , May 10, 2023 /PRNewswire/ -- Young children, ages 2 to 4 years, especially those with parental history of asthma, suffered the highest rates of asthma with recurrent exacerbations (ARE) over a nearly 30-year period studied in new research funded by the Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health.

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today provided financial results for the three months ended March 31, 2023, as well as a clinical and business update.

Nephros, Inc., a leading water technology company providing filtration solutions to the medical and commercial markets, announced financial results for the first quarter ended March 31, 2023.

Generation Bio Co. (Nasdaq: GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, reported business highlights and first quarter 2023 financial results.

Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three months ended March 31, 2023 and provides a business update.

Crinetics Pharmaceuticals, Inc. announced that on May 10, 2023, the Compensation Committee of Crinetics’ Board of Directors granted non-qualified stock option awards to purchase an aggregate of 295,000 shares of its common stock to nine new non-executive employees under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan.

Nordic Scaleup Award also recognizes the company’s long-term commitment to sustainability STOCKHOLM--( BUSINESS WIRE )-- Nordic Scaleup Summit-- Kerecis , the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, today received the Nordic Scaleup Award for 2023. The Nordic Scaleup Award recognizes high-growth companies that demonstrate best-of-class business performance in growing their compani